Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA greenlights first non-opioid treatment for severe pain in 20 years
Journavax was shown in clinical trials to be safe and effective, with no addictive potential.
PCI before TAVR linked to better outcomes than performing both at once
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
Swedish total artificial heart tech granted FDA’s humanitarian use designation
Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.
New findings prompt experts to call for routine brain imaging of certain breast cancer patients
New research suggests more women with late-stage breast cancer may develop brain metastases than previously believed.
Medical device company raises $36M for emitter-free IVL platform
Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.

Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.

Using a TAVR-like minimalist approach for valve-in-valve TMVR is safe and effective, Cleveland Clinic study confirms

During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.

Subclinical leaflet thrombosis after TAVR CT JAMA Cardiology OAC

Subclinical leaflet thrombosis after TAVR: What we know, and still need to learn, about a challenging complication

Treating subclinical leaflet thrombosis after TAVR has been an ongoing challenge for structural heart clinicians, but recent research has gone a long way toward improving our understanding of this important topic.

LaPrincess Brewer, M.D., a Mayo Clinic preventive cardiologist and principal investigator of the study, explains a heart model.

An immediate impact: Smartphone app boosts health of Black patients in just 10 weeks

A new trial for participants from 16 church groups in Minnesota showed that app users significantly improved their heart health scores after just 10 weeks.

Restricting salt intake too much may backfire for some heart patients

Limiting salt is a common recommendation for patients hoping to improve their heart health or lose weight. According to a new analysis of more than 1,700 patients, however, going too far with such restrictions can lead to worse outcomes.

Programmable RNA-DNA anticoagulant fibers may provide a better balance between blood clots and bleeding risks

“We can learn from nature, but we have built something that has never been introduced before,” one researcher said.

Radiologist starting salaries up 13.5% over last year

Radiologists are receiving salary offers averaging $455,000 to start a new job in 2022, up from $401,000 in 2021.

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

TAVR outcomes take a hit when patients present with heart failure or hypertrophic cardiomyopathy

In-hospital mortality was especially high among TAVR patients presenting with hypertrophic cardiomyopathy, according to a new analysis.

Autoimmune patients caught in crossfire of Supreme Court's Roe decision

Some patients with certain autoimmune diseases are finding it difficult to obtain their prescriptions for methotrexate as a result of changing abortion care laws.

Clinical

FDA greenlights first non-opioid treatment for severe pain in 20 years

PCI before TAVR linked to better outcomes than performing both at once

Swedish total artificial heart tech granted FDA’s humanitarian use designation

New findings prompt experts to call for routine brain imaging of certain breast cancer patients

Medical device company raises $36M for emitter-free IVL platform